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Long-term ingestion of inorganic arsenic
causes various health effects, including can-
cers of the bladder, skin, and lung and
development of skin lesions (1). The bio-
transformation of arsenic in humans occurs
through the methylation process. Few data
exist that link methylation patterns to
arsenic-induced disease (2,3). Although it
has been suggested that genetic polymor-
phisms cause variation in arsenic methyla-
tion (4–7), little evidence has been found to
substantiate this hypothesis.
Family correlation studies assist in deter-
mining whether variations in methylation
patterns may be caused by genetic polymor-
phisms. If genetic factors contribute to arsenic
methylation capacity, family studies should
demonstrate that siblings have a higher corre-
lation of methylation activity than their par-
ents. The application of family correlation
studies such as this was used to determine
whether there were genetic polymorphisms in
drug methylation systems (8,9).
Ingested inorganic arsenic (InAs) is methy-
lated in two steps, ﬁrst to monomethylarsenate
(MMA) and then to dimethylarsinate
(DMA). The total of urinary InAs, MMA,
and DMA is considered a biomarker of
recent inorganic arsenic exposure (10).
Methylation patterns can be assessed by the
relative distributions in urine of inorganic
arsenic and its metabolites (InAs, MMA, and
DMA) (7). The activity of the ﬁrst methyla-
tion step is indicated by the index
InAs/methylated arsenic (metAs), the ratio of
inorganic arsenic to the sum of methylated
arsenic species (MMA + DMA). A high ratio
of InAs/metAs indicates poor methylation at
the first step. The activity of the second
methylation step is represented by the ratio
of MMA to DMA (MMA/DMA) (11,12). If
the MMA/DMA ratio is high, there is poor
methylation at the second step. Population
studies have demonstrated that generally the
relative distribution is in the range of
10–30% InAs, 10–20% MMA, and 60–80%
DMA in populations exposed to arsenic
(2,13). There is an emerging hypothesis that
methylated forms of arsenic may play a larger
role in arsenic toxicity (14).
The aim of this analysis was to deter-
mine whether arsenic methylation has a
familial component. The conditions of Chiu
Chiu, a small village in northern Chile, were
ideal for evaluating familial correlations of
arsenic methylation. Because of Chiu Chiu’s
extremely dry desert environment, all of its
residents shared the sole drinking water sup-
ply to the village, which contained high lev-
els of arsenic. 
Materials and Methods
Study population. Selection of the Chiu
Chiu study site in Chile is explained in detail
elsewhere (15). For many years, Chiu Chiu’s
drinking water was piped in and until only
recently had high arsenic content (750–800
µg/L). Chiu Chiu has approximately 250
permanent residents, who share this drink-
ing water supply. 
The 11 participating families in this
cross-sectional study were selected if a)
members of the family included one adult
male (father), one adult female (mother),
and two biologically related children older
than 5 years of age, b) the two adults had
lived in Chiu Chiu for at least 10 years, c)
the children had been born in Chiu Chiu
and resided there since birth, and d) the
family’s water source was the village supply.
When a family had more than two children,
the two children closest to 10 years of age
were invited to participate. Initially we
sought families in which both adults had
lived and worked in Chiu Chiu for at least
20 years. When all the families meeting this
criteria in the village were exhausted, we
began admitting families in which one adult
had 20 years of residence and the other had
at least 10 years. The families selected were
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We investigated the evidence of a familial contribution to urinary methylation patterns in families
ingesting arsenic in drinking water. Arsenic methylation can be assessed by measuring urinary lev-
els of inorganic arsenic (InAs) and its methylated metabolites, monomethylarsonate (MMA), and
dimethylarsinate (DMA). Methylation activity is reﬂected in the ratios: InAs/methylated arsenic
(InAs/metAs) and MMA/DMA. Eleven families from Chile were selected because of their long-
term exposure to very high levels of arsenic in drinking water (735–762 µg/L). Each family con-
sisted of a father, a mother, and two children. We measured urinary arsenic and its methylated
metabolites for each participant (n = 44). The intraclass correlation coefficients showed that
13–52% of the variations in the methylation patterns were from being a member of a specific
family. Family correlations were calculated for father–mother, parent–child, and sibling–sibling
pairs. Methylation patterns correlated strongly between siblings [r = 0.78 for InAs/metAs, 95%
conﬁdence interval (CI), 0.34–0.94; r = 0.82 for MMA/DMA, 95%CI, 0.43–0.95] compared to
lower correlations in father–mother pairs (r = 0.18, r = –0.01, respectively), after adjustment for
total urinary arsenic, age, and sex. Family correlations were not notably altered when adjustments
were made for speciﬁc blood micronutrients (methionine, homocysteine, folate, vitamin B6, sele-
nium, and vitamin B12) potentially related to methylation. We also report on a family pedigree
with high prevalence of arsenic-induced effects. Participants from this family had low InAs/metAs
values, which is consistent with increased toxicity of trivalent methylated arsenic species. Despite
our small sample size, we observed that methylation patterns aggregate in families and are corre-
lated in siblings, providing evidence of a genetic basis for the variation in arsenic methylation.
Larger studies with more extensive pedigrees will need to be conducted to conﬁrm these ﬁndings.
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village that met these criteria. Each partici-
pant was interviewed for residential and
smoking histories and examined by four
physicians for arsenic-induced skin lesions
(keratoses, hypopigmentation, and hyperpig-
mentation). Informed consent was obtained
from all participants.
Sampling and chemical analysis. Spot
urine samples were collected for each partici-
pant and kept frozen at –20°C until they
were transported to the University of
Washington in Seattle for arsenic content
analysis. Urinary concentrations of InAs,
MMA, and DMA were determined using
hydride generation atomic absorption spec-
troscopy (HGAA) according to a method
based on that described by Crecelius (16). In
summary, inorganic arsenic (As3+ and As5+),
MMA, and DMA are reduced to the corre-
sponding arsine in a batch reactor using
sodium borohydride using 5-mL samples.
The volatile reduction products (arsine,
methyl arsine, and dimethyl arsine, respec-
tively) are removed by sparging with helium.
Entrained arsines are concentrated in a chro-
mosorb-ﬁlled cryogenic trap at liquid nitro-
gen temperatures until all arsine-forming
arsenic in the sample has reacted. The cry-
otrap is then allowed to warm, and the col-
lected arsines are separated on the basis of
differential volatilization. The detection of
the separated volatile arsenic species is
accomplished by atomic absorption spec-
troscopy using a hydrogen microburner com-
bustion cell to convert arsines to elemental
arsenic. Detection limits for InAs, MMA,
and DMA were 0.5, 1.0, and 2.0 µg/L,
respectively. In this paper, total urinary
arsenic refers to the total of InAs, MMA, and
DMA measured. The methylation indices,
percentages of InAs, MMA and DMA
(%InAs, %MMA, %DMA), and the ratios
(InAs/metAs, MMA/DMA) were calculated. 
Three water samples were obtained from
different locations in Chiu Chiu and
shipped to the University of Washington for
analysis. They were analyzed for arsenic con-
tent by HGAA according to a procedure
similar to that used for urine specimens (17). 
Blood samples were obtained from all
participants. Blood was aliquoted immedi-
ately and kept frozen until analysis. Pacific
Biometrics, Inc. (Seattle, WA, USA) super-
vised and performed most serum and plasma
nutrient analyses. Methods used for each
nutrient are brieﬂy presented. We measured
plasma homocysteine by HPLC using an
internal standard and monobromobimane
derivatization (18). We determined vitamin
B6 (pyridoxal phosphate) by HPLC and ﬂu-
orescence detection involving precolumn
derivatization of plasma vitamers with
sodium bisulfite (19). We analyzed serum
levels of vitamin B12 and folate by CEDIA
assays (20). Serum selenium was measured
by graphite furnace atomic absorption spec-
trophotometry at the Nutrition Research
Laboratory in the Department of Laboratory
Medicine at the University of Washington,
or by inductively-coupled plasma mass spec-
tometry by the Associated Regional and
University Pathologists’ trace mineral labora-
tory at the University of Utah Health
Science Center (Salt Lake City, UT). Plasma
methionine was measured by amino acid
analyzer using a cation-ion exchange column
at the Scientific Research Consortium, Inc.
(St. Paul, MN). 
Statistical analysis. Statistical analyses
were performed using SAS software (SAS
Institute, Cary, NC, USA) for analysis of
variance (ANOVA) and correlational analy-
ses, and STATA for intraclass ANOVA (21).
We compared the arsenic methylation
indices across family members by ANOVA.
We computed intraclass correlations to eval-
uate the correlation within families. This
correlation is the proportion of variation of
the methylation index that is explained by
being in a specific family. The intraclass
correlation is the Pearson product–moment
correlation computed over all possible pairs
of family members within the family. 
We examined family resemblance pat-
terns in arsenic methylation by estimating
Pearson correlation coefﬁcients between pairs
of family members. We examined interclass
correlations between father and mother,
parent and child, and between siblings.
Parent–child pairs were evaluated with each
parent to each child. To evaluate whether
there were independence concerns with
including both children, we also used aver-
ages of the siblings in analyses. These results
are not reported because they did not differ
notably from the results including all pairs.
The family correlations were also con-
ducted with residual values. We adjusted the
urinary arsenic methylation indices by multi-
ple regression for age and sex, and then includ-
ing total urinary arsenic for some analyses: 
y ˆ (methylation index predicted) = b1(age)
+ b2(sex) + [b3(total arsenic)].
We obtained the residual values from the
difference of the actual value and the pre-
dicted value estimated from the regressions
of the methylation indices:
residual = yi (observed) – y ˆ (predicted) (i
= 1,2,…,44 for each participant). 
These residual values reﬂect the variation
after the effects of the regression variables have
been removed. Smoking and body mass index
(kilograms per square meter) were added to
the models, but did not change the results. 
To evaluate whether nutritional factors
may modify the correlations between family
members, we adjusted for specific blood
micronutrients and biochemical indicators
known to be involved in the arsenic methy-
lation pathway. We adjusted for methionine,
homocysteine, folate, vitamin B6, selenium,
and vitamin B12 (cobalamin) separately.
Each nutrient or indicator was added to the
regression, and interclass correlations were
computed with the residual values. 
Results
Information on the 11 families is presented
in Table 1. Four adult men had arsenic-
induced skin lesions (15). In one family,
both the daughter and her father had skin
lesions. Most smokers were men. All ex-
smokers had stopped smoking more than 5
years before the study. We measured arsenic
concentrations at 735, 762, and 763 µg/L
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Table 1. Information on 11 families participating in study.
Characteristics Fathers (n = 11) Mothers (n = 11) Sons (n = 14) Daughters (n = 8)
Mean age, years (range) 38 (30–50) 36 (26–47) 10 (6–14) 11 (9–14)
Mean BMI, kg/m2 (range) 25.8 (22.1–27.0) 26.6 (20.7–37.3) 19.2 (15.3–30.3) 18.3 (15.7–22.3)
No. with skin lesions 4 0 0 1
No. of current/ex-smokers 4/3 1/1 0 0
BMI, body mass index.
Table 2. Distribution of urine-based arsenic methylation indices by family membership, mean (range).
Methylation index All (n = 44) Fathers (n = 11) Mothers (n = 11) Sons (n = 14) Daughters (n = 8) p-Valuea
Mean total arsenic (µg/L) 490 (55–1,320) 464 (184–1,026) 466 (161–773) 566 (55–1,320) 427 (260–736) 0.60
%InAs 17 (6–32) 20 (9–32) 15 (6–25) 15 (8–22) 18 (7–28) 0.22
%MMA 14 (3–25) 18 (11–25) 11 (4–17) 13 (3–19) 14 (10–20) < 0.01
%DMA 69 (49–86) 62 (49–75) 74 (58–83) 72 (59–86) 68 (55–81) 0.02
InAs/metAs 0.21 (0.07–0.47) 0.25 (0.10–0.47) 0.18 (0.07–0.33) 0.18 (0.09–0.29) 0.22 (0.07–0.39) 0.20
MMA/DMA 0.22 (0.03–0.46) 0.30 (0.15–0.46) 0.16 (0.05–0.29) 0.19 (0.03–0.31) 0.22 (0.03–0.35) < 0.01
aFor ANOVA.from three samples of Chiu Chiu drinking
water, conﬁrming high arsenic content. 
Chiu Chiu participants had elevated total
urinary arsenic levels (average 490 µg/L),
which confirms high exposure to arsenic
(Table 2). The average distributions of uri-
nary arsenic metabolites were 17% InAs, 14%
MMA, and 69% DMA. The average for
InAs/metAs was 0.21, and for MMA/DMA
0.22. Overall, the distributions did not differ
between fathers, mothers, sons, and daughters
for total arsenic levels, %InAs, and the ratio of
InAs/metAs. However, fathers have higher
%MMA and MMA/DMA ratio and lower
%DMA. InAs/metAs and MMA/DMA ratios
were plotted for each individual by family in
Figure 1. 
The intraclass correlations for Chiu Chiu
indicate familial aggregations of methylation
patterns (Table 3). The intraclass correla-
tions for families were r = 0.52 for %InAs,
0.13 for %MMA, 0.32 for %DMA, 0.45 for
InAs/metAs, and 0.38 for MMA/DMA.
Between 13 and 52% of the variations of all
the methylation indices can be explained by
being a member of a speciﬁc family. 
Results of the family resemblance corre-
lation analyses are presented in Table 4. The
unadjusted and adjusted interclass correla-
tion coefficients (r), 95% confidence inter-
vals (CI), and p-values are shown. High
correlations were found between siblings for
all variables (r = 0.82 for %InAs; 0.62 for
%MMA; 0.82 for %DMA; 0.80 for
InAs/metAs; 0.76 for MMA/DMA). The
parent–child correlations were much lower
(0.16–0.50). The correlations between the
fathers and mothers were also lower
(0.21–0.46). 
Correlations of the residual values from
speciﬁc regression models adjusting for total
urinary arsenic, age, and sex are further
deﬁned (Table 4). The correlations between
siblings remained high (r = 0.74 for %InAs,
95% CI, 0.26–0.93; r = 0.69 for %MMA,
95% CI, 0.15–0.91; r = 0.83 for %DMA,
95% CI, 0.47–0.96; r  = 0.72 for
InAs/metAs, 95% CI, 0.22–0.92; r = 0.78
for MMA/DMA, 95% CI, 0.43–0.94).
However, the parent–child (r = –0.01–0.31)
and father–mother (r = –0.02–0.26) correla-
tions were lower. The adjusted correlations
are presented graphically in Figure 2. 
Even after adjusting for individual blood
levels of micronutrients and biochemical
indicators (methionine, homocysteine,
folate, vitamin B6, selenium, vitamin B12),
the sibling correlations remained high. After
adjusting for folate and homocysteine, the
father–mother correlations for InAs/metAs
increased. The correlations and regression
coefficients are shown for InAs/metAs and
MMA/DMA in Table 5. 
We also report on characteristics of
family A. Both the father and daughter had
skin lesions. We then discovered that the
son, who had not participated in the study,
also had arsenic-induced skin cancer. Upon
further investigation of their family pedi-
gree (Figure 3), we found among three
generations of this family that six out of 10
members who lived in Chiu Chiu have
developed arsenic-related health effects
(squamous cell carcinoma, Bowen’s dis-
ease, and skin lesions). Additionally, the
InAs/metAs ratios for all four members of
Family A are among the lowest six values
of the entire study (see Figure 1A). The
probability that four participants who rank
this low are in one particular family, by
chance alone, is < 0.001. 
Discussion
This investigation is the first of its kind to
evaluate the degree of familial resemblance
for arsenic methylation capacities. Chiu
Chiu families were an ideal population to
study because the residents consumed the
same highly arsenic-contaminated water for
many years, the only water source in this
extremely dry desert region. High intraclass
correlations for the participating families
indicate that methylation is more similar
among relatives than among unrelated indi-
viduals. We found signiﬁcant correlations of
urinary methylation indices between sib-
lings, which suggests that the capacity to
metabolize arsenic has a familial component. 
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Table 3. Intraclass correlations (r) and SE for families of urine-based methylation indices. 
Methylation index Intraclass correlation (r ± SE) p-Valuea
%InAs 0.52 ± 0.16 < 0.01
%MMA 0.13 ± 0.15 0.16
%DMA 0.32 ± 0.17 0.01
InAs/metAs 0.45 ± 0.16 < 0.01
MMA/DMA 0.38 ± 0.17 < 0.01
aFor ANOVA.
Figure 1. Urine-based arsenic methylation indices plotted for each participant by family. (A) ratio of inor-
ganic arsenic to methylated arsenic (InAs/metAs) and (B) ratio of MMA/DMA. 
*Families that had at least one family member diagnosed with arsenic-induced skin lesions. Family A is boxed (see Figure 3).
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Table 4. Interclass correlation coefficients (r) and 95% CI between pairs of family members for urine-
based methylation indices.
Methylation index Adjusted for total
correlation for Adjusted for urinary arsenic,
family pair Unadjusted age and sex age, and sex 95% CI p-Value
%InAs
Father–mother 0.46 0.47 0.26 –0.40–0.75 0.43
Parent–child 0.50 0.49 0.31 –0.01–0.55 0.04
Sibling–sibling 0.82 0.83 0.74 0.26–0.93 < 0.01
%MMA
Father–mother 0.21 0.14 0.01 –0.59–0.61 0.97
Parent–child 0.16 0.14 0.02 –0.28–0.32 0.89
Sibling–sibling 0.62 0.63 0.69 0.15–0.91 < 0.01
%DMA
Father–mother 0.25 0.26 –0.02 –0.61–0.59 0.96
Parent–child 0.33 0.32 0.12 –0.18–0.40 0.44
Sibling–sibling 0.82 0.82 0.83 0.47–0.96 < 0.01
InAs/metAs
Father–mother 0.38 0.39 0.18 –0.47–0.70 0.60
Parent–child 0.43 0.42 0.26 –0.04–0.52 0.08
Sibling–sibling 0.80 0.81 0.72 0.22–0.92 < 0.01
MMA/DMA
Father–mother 0.21 0.18 –0.01 –0.60–0.60 0.98
Parent–child 0.18 0.15 –0.01 –0.31–0.29 0.95
Sibling–sibling 0.76 0.75 0.78 0.43–0.94 < 0.01Genetic polymorphisms have explained
differences in other methylation systems (22),
so it is likely that arsenic methylation may also
be genetically determined. If so, individual
susceptibility caused by differences in arsenic
methylation capacity may be inherited. Few
studies have investigated familial patterns and
genetic factors in development of arsenic
health effects and metabolism. In Taiwan, a
population-based study found that patients
with blackfoot disease, an arsenic-induced
peripheral vascular disease, were three times
more likely to have a family history of black-
foot disease than community controls (23).
However, exposure variation could account
for this pattern. A case report from the
Netherlands described an entire family
exposed to a pesticide containing arsenite
(24). Among all the family members
exposed, only the young female in the fam-
ily, with a 5,10-methylenetetrahydrofolate
reductase (MTHFR) deﬁciency, had elevated
homocysteine in the plasma and urine and
showed neurotoxic symptoms after exposure
(24). A specific genetic polymorphism for
MTHFR which may be involved in arsenic
methylation could have contributed to her
susceptibility to arsenic. 
Another study from Taiwan found that
genetic polymorphisms of the detoxiﬁcation
enzymes glutathione S-tranferases M1 and
T1 were associated with varying arsenic
methylation patterns (6). The researchers
found that those with the null GSTM1
genotype had a higher percentage of %InAs,
and those with the null GSTT1 genotype
had increased %DMA in the urine. Studies
conducted in native Andean populations
from Argentina have found unusually low
fractions of urinary MMA (~ 2%) (5,25)
compared to levels in populations elsewhere.
It has been postulated that a genetic poly-
morphism controlling arsenic-methylating
enzymes accounts for the interindividual
variation across populations (4,12). 
In this investigation, we reported on family
A, which presents an interesting family history
of arsenic-related health effects. Family mem-
bers who resided in Chiu Chiu had a high
prevalence of arsenic-induced skin lesions. It
had been thought that methylation reduced
the toxicity of arsenic (12), but recent labora-
tory evidence suggests that methylated trivalent
MMA may be more toxic than the inorganic
forms (14,26). The low values of InAs/metAs
found in family A could indicate that the bio-
transformation of arsenic through methylation
may be associated with increased health effects.
The particular characteristics of family A and
its extended pedigree may be an example of a
genetic predisposition in methylation resulting
in susceptibility to the effects of arsenic.
The children’s methylation indices were
consistent with those measured in children
in Mexico and Belgium (27,28). In contrast,
they were not consistent with the low
%MMA reported in one study from
Argentina (25). The high sibling–sibling cor-
relations of all methylation indices are
intriguing. Variation in arsenic methylation
is likely caused by both genetic factors and
environmental effects. The children in this
Articles • Chung et al.
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Figure 2. Family resemblance correlations. Bar graph of the interclass correlation coefﬁcients (r) of each
urine-based arsenic methylation index between family pairs (father–mother, parent–child, and
sibling–sibling) adjusted for total urinary arsenic, age, and sex (n = 11 families).
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Table 5. Interclass correlations (r) between pairs of family members adjusted for blood levels of speciﬁed
nutritional factors, total urinary arsenic, age, and sex.
Methylation index/nutritional factor Father–mother Parent–child Sibling–sibling
InAs/metAs
No nutritional adjustment 0.18 0.26 0.78
Folate (ng/mL) 0.33 0.21 0.65
Methionine (µmol/L) 0.14 0.27 0.73
Vitamin B6 (nmol/L) 0.26 0.22 0.67
Vitamin B12 (pg/mL) 0.09 0.22 0.65
Selenium (µmol/L) 0.20 0.27 0.70
Homocysteine (µmol/L) 0.55 0.27 0.67
MMA/DMA
No nutritional adjustment –0.01 –0.01 0.82
Folate (ng/mL) 0.06 –0.02 0.77
Methionine (µmol/L) –0.03 0.03 0.76
Vitamin B6 (nmol/L) –0.11 –0.09 0.73
Vitamin B12 (pg/mL) –0.01 –0.01 0.79
Selenium (µmol/L) 0.04 0.01 0.76
Homocysteine (µmol/L) 0.26 0.00 0.80
Figure 3. Pedigree of family A. D, daughter; F, father; M, mother. Some individuals lived in areas consid-
ered unexposed to arsenic; all other individuals lived in Chiu Chiu. Skin lesions are represented in blue.
Skin cancers (squamous cell carcinoma and Bowen’s disease) are represented in black.
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Participants in the study
Those in unexposed areasstudy were born into environments with
arsenic exposure. The sibling–sibling correla-
tions may be influenced by environments
shared only by the children, such as home,
school, or play areas, or there may have been
a cohort effect. The lower parent–child cor-
relations may be a result of genetic effects
associated with metabolism being more
important and pronounced at younger ages. 
An important limitation of this study
involves its size. Although the population is
unique because there was only one drinking
water source for these families, the small sam-
ple size precludes definitive differentiation
between genetic and environmental contribu-
tions to family correlations. Examination of the
conﬁdence intervals in Table 4 suggests that
the sibling–sibling correlations are indeed real.
However, the conﬁdence interval limits for the
father–mother and parent–child correlations
are quite high, suggesting caution is needed in
interpretation of these particular ﬁndings.
Despite the small sample size, the pre-
sent study provides evidence of a familial
component, supporting a genetic basis for
arsenic methylation. This study is a ﬁrst step
in establishing familial patterns. In this
analysis, adjustments were made for blood
levels of micronutrients and biochemical
indicators to control for nutritional factors
that may be involved in methylation. We are
not able to conclude whether there is an
effect from nutritional factors on methyla-
tion or on any gene–environment interac-
tions. The relative contributions of heredity
and shared environment to the familial
resemblance and possible modes of inheri-
tance will require more research. 
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